TriSalus Life Sciences (TLSI) Share-based Compensation (2022 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Share-based Compensation of $2.5 million for Q1 2026, up 52.59% year-over-year from $1.6 million in Q1 2025, and down 72.93% quarter-over-quarter from $9.1 million in Q4 2025.
TriSalus Life Sciences (TLSI) Share-based Compensation (2022 - 2026) Analysis & Trends
TriSalus Life Sciences' Share-based Compensation history runs 5 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- In Q1 2026, Share-based Compensation rose 52.59% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $10.0 million (up 67.08% YoY), while the FY2025 annual figure was $9.1 million, up 67.82% from the prior year.
- Share-based Compensation for Q1 2026 stood at $2.5 million, down from $9.1 million in the prior quarter.
- The five-year high for Share-based Compensation was $9.1 million in Q4 2025, with the low at -$3.5 million in Q3 2025.
- The 5-year median for Share-based Compensation is $744000.0 (2023), against an average of $1.2 million.
- Peak annual rise in Share-based Compensation reached 1822.97% in 2024, while the deepest fall reached 571.89% in 2024.
- TriSalus Life Sciences' Share-based Compensation stood at $117000.0 in 2022, then tumbled by 443.59% to -$402000.0 in 2023, then surged by 1338.06% to $5.0 million in 2024, then jumped by 83.46% to $9.1 million in 2025, then tumbled by 72.93% to $2.5 million in 2026.
- Business Quant data shows TLSI's Share-based Compensation at $2.5 million in Q1 2026, $9.1 million in Q4 2025, and -$3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 12.80 Mn |
| 10 | TriSalus Life Sciences | 306.64 Mn | 260.35 Mn | 9.90 Mn | 2.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.62 Mn |
| Jun 30, 2026 | 2.62 Mn |
| Mar 31, 2026 | 2.47 Mn |
| Mar 31, 2026 | 2.47 Mn |
| Dec 31, 2025 | 9.13 Mn |
| Dec 31, 2025 | 9.13 Mn |
| Sep 30, 2025 | -3.51 Mn |
| Sep 30, 2025 | -3.51 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Mar 31, 2025 | 1.62 Mn |
| Mar 31, 2025 | 1.62 Mn |
| Dec 31, 2024 | 4.98 Mn |
| Dec 31, 2024 | 4.98 Mn |
| Sep 30, 2024 | -1.90 Mn |
| Sep 30, 2024 | -1.90 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 1.09 Mn |
| Mar 31, 2024 | 1.09 Mn |